January 4, 2023   USA
outcomesrocket.health: Research is always about rising from failure
Podcast interview with Ulf Hannelius, CEO of Diamyd Medical, presenting insight into the key factors supporting Diamyd Medical's research and development for a new medicine for Type 1 Diabetes.

Outcomes Rocket Network is a podcast network that creates distinguished results through conversations with the most inspiring leaders in healthcare.

Listen to the interview here
Information presented here are not press releases and may include excerpts from and links to externally published content. Diamyd Medical is not responsible for externally published content.

Order GAD for preclinical research